Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 2, 2020
- Accepted December 28, 2020
- Published online January 15, 2021.
Article Versions
- You are currently viewing a previous version of this article (January 15, 2021 - 10:29).
- View the most recent version of this article
Copyright & Usage
Copyright © 2021, Parenteral Drug Association
Author Information
- Allison Scott1,9 (a.scott.x4{at}biovigilant.azbil.com),
- Ren-Yo Forng2 (rforng{at}amgen.com),
- Mike Russ3 (meruss{at}gene.com),
- Gilberto Dalmaso4 (dalmasogilberto1963{at}gmail.com),
- Scott Hooper5 (scott_hooper{at}merck.com),
- Philip Villari5 (philip_villari{at}merck.com),
- James Cannon6 (jim.cannon{at}mt.com),
- James Francis7 (j.francis{at}micronview.com) and
- Mike Dingle8 (michael.dingle{at}tsi.com)
- 1 Azbil North America Research and Development: BioVigilant;
- 2 Amgen;
- 3 Genentech/Roche;
- 4 GDM Pharma Consulting;
- 5 Merck & Co., Inc.;
- 6 Mettler-Toledo Thornton, Inc.;
- 7 Micron View Limited;
- 8 TSI, Inc.
- ↵* Corresponding author; email: a.scott.x4{at}biovigilant.azbil.com
